Gilead stock could finally have breakout year, Barron’s says

Investors have been waiting years for Gilead Sciences to finally recover from its blowup in 2016. That could finally happen in 2024, Jacob Sonenhine writes in this week’s edition of Barron’s. Keeping the same multiple in place and including the dividend, the stock could post an almost double-digit total return by the end of the coming new year. If things go right, there’s lots of additional upside ahead, the author says.